FAM196A Activators
FAM196A Activators comprise a specific set of chemical compounds that indirectly enhance the functional activity of FAM196A through a variety of signaling pathways. Forskolin, by increasing intracellular cAMP levels, activates PKA, which may phosphorylate proteins that interact with FAM196A, thereby enhancing its activity. Similarly, PMA activates PKC, which phosphorylates proteins in the signaling networks associated with FAM196A, potentially leading to an enhancement of FAM196A's activity. S1P, through its action on G protein-coupled receptors, initiates signaling cascades affecting the actin cytoskeleton, potentially influencing FAM196A's activity by altering cellular structural dynamics. EGCG, with its kinase inhibitory properties, can lead to the reduced inhibition of proteins in the same pathway as FAM196A, thereby indirectly enhancing FAM196A's functional role. Additionally, LY294002 and Wortmannin, by specifically inhibiting PI3K, can modify phosphorylation states of downstream signaling molecules, which could lead to an increase in FAM196A activity.
The activity of FAM196A is further influenced by compounds that modulate other signaling pathways, such as U73122 and SB203580, which inhibit PLC and p38 MAP kinase, respectively. These inhibitors can change the signaling landscape within the cell, possibly resulting in the enhancement of FAM196A activity through altered protein-protein interactions or pathway engagement. Calcium ionophores like A23187 and Ionomycin elevate intracellular calcium levels, potentially leading to the activation of calcium-dependent signaling pathways that can enhance FAM196A activity. Dibutyryl-cAMP, another cAMP analog, activates PKA, further emphasizing the role of cAMP-mediated signaling in the regulation of FAM196A. Lastly, Genistein's inhibition of tyrosine kinases may diminish competitive signaling, thereby permitting an increase in FAM196A activity through less obstructed signaling pathways. Collectively, these activators influence the cellular signaling milieu in a manner that converges on the enhancement of FAM196A function, without directly increasing its expression or requiring direct activation of the protein itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC activation can lead to phosphorylation of proteins that are part of the same signaling network as FAM196A, potentially enhancing its activity by modulating the protein-protein interactions in which FAM196A is involved. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its G protein-coupled receptors, initiating signaling cascades that can lead to actin cytoskeletal rearrangements. FAM196A, being associated with cellular structure, could have its activity enhanced by the cytoskeletal changes induced by S1P signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a catechin found in green tea with kinase inhibitory activity. By inhibiting certain kinases, EGCG could reduce phosphorylation-based inhibition of proteins in the same pathway as FAM196A, thus indirectly enhancing FAM196A's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K). PI3K inhibition can alter the phosphorylation states of downstream signaling molecules, potentially leading to increased activity of FAM196A if it is part of those signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. By inhibiting p38 MAPK, SB203580 can shift the signaling dynamics within the cell, potentially leading to enhanced activity of FAM196A if it is interconnected with the p38 MAPK pathway. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels. Elevated calcium levels can activate calcium-dependent signaling pathways and proteins, which may include pathways that enhance FAM196A activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. By activating PKA, it can stimulate the phosphorylation of proteins that modulate FAM196A activity or its association with other proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore like A23187, and it increases intracellular calcium concentration. This elevation in calcium could activate pathways or cellular processes that enhance the activity of FAM196A. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. Similar to LY294002, Wortmannin's inhibition of PI3K can affect downstream signaling events that might lead to an increase in FAM196A activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an inhibitor of tyrosine kinases. By inhibiting tyrosine kinase activity, it might reduce competitive signaling events, potentially allowing pathways that involve FAM196A to become more active. | ||||||